Indian pharma manufacturers are vital to the global medicine supply, but they're grappling with a huge challenge that affects both business and patient safety. At the heart of the problem lies the struggle to consistently meet strict international quality standards. The scrutiny from regulators like the USFDA is higher than ever, putting companies under pressure to update systems and processes. From data integrity issues to the real costs of compliance, the struggle to keep up is intense. This article explores why this is happening and what the industry can do about it.
pharma manufacturers India